Skepticism to Standard of Care: The T-Cell Journey, ft. Dr. James Mulé
The ImmunoVerse™
00:00
Discovery and Early Trials of Tumor‑Infiltrating Lymphocytes (TIL)
Dr. Patrick Hwu asks about TILs; Mulé traces TIL discovery in mice, translation to human expansion, and therapeutic results leading toward clinical use.
Play episode from 07:56
Transcript
